文献速递慢性肾脏病

性别肯定激素治疗对跨性别退伍军人肾功能轨迹的影响

The Effect of Gender-Affirming Hormone Treatment on Kidney Function Trajectories in Transgender and Gender-Diverse Veterans.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-06-19

本研究为2006至2019年退伍军人健康管理局的纵向队列研究,纳入6616名退伍军人,其中262名接受激素治疗(214名跨性别女性,48名跨性别男性)。结果显示,跨性别男性使用睾酮后血清肌酐早期升高、eGFR斜率下降,而跨性别女性使用雌激素后eGFR保持稳定。提示激素治疗对肾功能影响存在差异,需个体化监测。

要点

  • 跨性别男性使用睾酮与eGFR斜率下降相关。
  • 睾酮启动后前12个月血清肌酐升高,12个月时趋于稳定。
  • 跨性别女性使用雌激素与eGFR斜率稳定相关。

核心结论

  • 激素治疗对跨性别退伍军人的肾功能影响存在差异,跨性别男性使用睾酮与eGFR下降相关,跨性别女性使用雌激素与eGFR稳定相关。

研究设计与样本

  • 纵向队列研究,使用退伍军人健康管理局2006年1月至2019年12月的数据,纳入6616名退伍军人,其中262名接受激素治疗,6354名顺性别对照。

主要发现

  • 跨性别男性接受激素治疗后,血清肌酐在3个月时升高,12个月时稳定;跨性别女性血清肌酐无显著变化。
  • 跨性别男性接受激素治疗后eGFR显著降低,而跨性别女性eGFR保持稳定。

临床怎么用

  • 对接受激素治疗的跨性别个体应进行个体化肾功能监测,并考虑优化eGFR计算方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Administration of testosterone was associated with decline in the slope of eGFR in transgender veterans. Administration of testosterone was associated with increase in creatinine in first 12 months of hormone initiation in transgender veterans. Administration of estrogen was associated with stability of eGFR slope in transgender veterans. BACKGROUND: The impact of hormone therapy (HT) on kidney function in transgender and gender-diverse (TGD) individuals remains poorly understood, and this lack of data poses challenges in caring for TGD individuals with kidney disease. The aim of this study was to compare serum creatinine levels and eGFR slope, a critical marker of kidney function, in transgender women (TW) and transgender men (TM) relative to cisgender (non-TGD) controls. METHODS: We conducted a longitudinal cohort study of veterans using Veterans Health Administration care from January 2006 to December 2019. Serum creatinine and eGFR were assessed using algorithms based on affirmed gender and sex assigned at birth. Within-group changes over time were assessed using generalized linear mixed-effect models with random intercept and time modeled as a categorical variable. Two-way fixed-effects models were used to assess changes in eGFR slopes relative to HT initiation compared with cisgender controls. RESULTS: The analytic dataset included 6616 veterans of whom 262 were receiving HT (214 [3%] TW and 48 [0.72%] TM) and 6354 were cisgender not receiving HT (1988 [30%] cisgender women and 4366 [66%] cisgender men). Serum creatinine was higher as early as 3 months after HT initiation in TM veterans with stabilization by 12 months, whereas TW veterans did not demonstrate any significant change in their serum creatinine. eGFR was significantly lower in TM veterans after HT initiation, whereas it remained stable in TW veterans. CONCLUSIONS: Our findings suggest that HT is associated with divergent effects on kidney function. These findings suggest the need for individualized kidney monitoring and potentially refined eGFR calculations for TGD populations.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Jackson N, Buljubasic N, Kalantar-Zadeh K, et al. The Effect of Gender-Affirming Hormone Treatment on Kidney Function Trajectories in Transgender and Gender-Diverse Veterans. Clin J Am Soc Nephrol. 2026. PMID: 42312556. doi:10.2215/CJN.0000001131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。